Ultrasound Needle Guides Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 334.79 Million |
| Market Size (2030) | USD 450.98 Million |
| CAGR (2025 - 2030) | 5.09% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Ultrasound Needle Guides Market Analysis
The Ultrasound Needle Guides Market size is estimated at USD 334.79 million in 2025, and is expected to reach USD 450.98 million by 2030, at a CAGR of 5.09% during the forecast period (2025-2030).
Several factors contribute to the growth of the ultrasound needle guides market, including the rising demand for minimally invasive procedures, advancements in ultrasound technology, and the growing prevalence of chronic diseases.
The increasing demand for minimally invasive procedures, including ultrasound-guided procedures, is attributed to the lower risks associated with interventions and enhanced precision in biopsies, catheter insertions, and regional anesthesia. Thus, with the rising demand for ultrasound-guided interventions, the adoption of ultrasound needle guides is anticipated to rise, further boosting market growth. For instance, an article published in the Journal of Ultrasonography in November 2023 highlighted that various medical and surgical subspecialties began utilizing sonographic guidance for percutaneous procedures, even for those typically done without such guidance, owing to the extensive use and familiarity with diagnostic ultrasound in the musculoskeletal system. The reliable verification of needle placement accuracy and the favorable outcomes associated with ultrasound-guided procedures, including enhanced patient comfort, led to this shift in practice patterns. Additionally, an article published in the Journal of Advanced Biomedical Research in April 2023 stated that ultrasound-guided percutaneous surgery resulted in quicker recovery and reduced pain levels compared to traditional open-release surgery for treating multiple trigger fingers. Thus, the preference for minimally invasive procedures is rising due to advantages such as patient comfort and reduction in recovery time, which, in turn, drives the demand for ultrasound needle guides, hence contributing to the market growth.
The integration of advanced technologies such as 3D/4D imaging, doppler technology, and real-time visualization improves the accuracy of needle placement, which is likely to be utilized by end-users. For instance, an article published in the Journal of Artificial Intelligence Surgery in July 2024, mentioned that a significant method to align the needle with the ultrasound beam involves optimizing the field of view for specific procedures, like 3D imaging. Promising results have been observed with 3D transducers aligning the needle within the ultrasound image. Additionally, 3D-rendered images have proven valuable in examining anatomical structures and assisting in catheter placement to distribute local anesthetics following peripheral nerve blocks in patients. Moreover, in July 2023, Konica Minolta Healthcare Americas, Inc. unveiled the PocketPro H2, a cutting-edge wireless handheld ultrasound system specifically customized for musculoskeletal (MSK) assessment, pain management, vascular access, and needle guidance applications. As a result, these advancements in ultrasound technology are expected to be adopted by both patients and healthcare professionals, driving significant growth in the market.
Therefore, the increasing demand for minimally invasive procedures and advancements in ultrasound technology are key contributors to market growth. However, a shortage of skilled professionals may hinder the growth of the ultrasound needle guides market during the forecast period.
Ultrasound Needle Guides Market Trends
The Biopsy Procedures Segment is Expected to Capture the Largest Share of the Ultrasound Needle Guides Market During the Forecast Period
Biopsy procedures are medical techniques employed to obtain tissue or cells from a specific part of the body for analysis, to diagnose diseases like cancer, infections, or inflammatory disorders. The increasing prevalence of cancer, growing adoption of minimally invasive techniques, and advancements in imaging technologies are expected to play a significant role in the growth of the studied segment throughout the forecast period.
The increasing prevalence of cancers, including breast, prostate, liver, and lung cancer, led to a higher demand for biopsies to confirm diagnoses. Ultrasound-guided needle biopsies are a minimally invasive option that offers high accuracy, making them a preferred choice in cancer care. For instance, as per the data updated by the Global Cancer Observatory in February 2024, it was predicted that there will be around 21.3 million and 24.1 million new cases of cancer by 2025 and 2030, respectively, across the world. Hence, with the rising number of new cancer cases, the demand for ultrasound-guided needle biopsy procedures is anticipated to rise, thereby driving the studied segment growth.
The significant advantages of ultrasound-guided biopsy is likely to enhance the adoption, which in turn, may contribute to the segment growth. For instance, an article published in the Journal of Diagnostics (Basel) in May 2023, mentioned that in differentiating between benign and malignant lesions, ultrasound-guided biopsy demonstrated excellent specificity, reaching up to 100%, along with very high sensitivity, ranging from 95% to 96%. Additionally, ultrasound-guided biopsy was highly effective, with an effectiveness rate of 83% to 98%, in identifying particular types of malignancies.
Further, government and non-governmental organizations focusing on promoting for early cancer detection by implementing screening programs, which has led to a rise in the number of biopsy procedures, thereby boosting the demands for ultrasound needle guides. For instance, in August 2024, the United States Department of Health and Human Services (HHS), via the Health Resources and Services Administration (HRSA), allocated nearly USD 9 million to 18 HRSA-supported health centers in the United States to enhance access to critical cancer screenings in underserved communities. Additionally, in June 2024, the Government of Andhra Pradesh, in partnership with the Homi Bhabha Cancer Hospital and Research Institute in Visakhapatnam, along with the World Health Organisation (WHO) provided technical support, launched a Comprehensive Cancer Screening Programme (CCSP) targeted at individuals aged 30 and older. This initiative focuses on screening for three prevalent types of cancer: breast cancer and oral cavity (dental) cancer. Hence, such government initiatives will enhance the demands for biopsy procedures, which further necessitates the ultrasound needle guides, and is anticipated to fuel the segment's growth.
Thus, owing to the above-mentioned factors, such as the rising prevalence of cancers, significant advantages of ultrasound-guided biopsy and increasing government initiatives, the segment growth is expected to continue.
North America is Likely to Hold the Largest Market Share for Ultrasound Needle Guides Market Over the Forecast Period
Several factors are driving the growth of North America's ultrasound needle guides market, including the increasing use of minimally invasive procedures, a higher prevalence of chronic diseases, and advancements in ultrasound imaging technology, alongside the established presence of major market participants.
The increasing rates of chronic illnesses like cancer, cardiovascular disease, and kidney disorders necessitate a large number of diagnostic and therapeutic interventions, including biopsies, ablations, and catheter placements. This high demand for procedures, in turn, is fueling the need for ultrasound needle guides and is expected to drive market growth in the region. For instance, as per the data published by the Canadian Cancer Society in May 2024, the number of new cancer cases in Canada was projected to rise to 247.1 thousand in 2024, up from 239.1 thousand in 2023. Moreover, as per the data published by the American Heart Association in January 2024, a heart attack strikes someone in the United States about every 40 seconds. Each year, there are around 605 thousand first-time heart attacks and 200 thousand subsequent attacks. Of these, an estimated 170 thousand are silent heart attacks, presenting no significant symptoms. Thus, the significant prevalence of chronic conditions like cancer and cardiovascular disease is anticipated to be a major factor fueling the growth of the ultrasound needle guide market in North America.
The healthcare providers are increasingly adopting advanced ultrasound-needle guides to streamline the procedure, thus bolstering the market growth. For instance, in February 2024, the UC Davis Health endoscopy team performed an endoscopic, ultrasound-guided core biopsy of a pancreatic tumor using the innovative EndoDrill GI needle. This novel procedure enabled the team to obtain a higher-quality core sample with the first needle pass, providing pathologists with additional tissue, which is expected to improve diagnostic accuracy. Thus, healthcare providers significantly employ ultrasound needle guides for performing biopsy procedures, which, in turn, drives the market growth.
Advanced technology-driven product launches by key market players are predicted to boost regional market growth. For instance, in November 2024, Mammotome introduced the Mammotome AutoCore Single Insertion Core Biopsy System, a groundbreaking automated spring-loaded core needle device. This innovative system represented a significant advancement over traditional methods, streamlining procedures for physicians and enhancing the patient experience. Its single-insertion design, developed with efficiency and ease of use, simplifies ultrasound-guided biopsies by minimizing procedural steps. Thus, the market's increasing adoption of innovative product advancements is expected to fuel market growth throughout the forecast period.
Therefore, owing to the above-mentioned factors, such as the increasing advancements in ultrasound imaging technology, rising adoption of ultrasound-needle guides by the end-users, and the escalating incidence of chronic conditions, the market in this region is projected to experience significant growth throughout the forecast period.
Ultrasound Needle Guides Industry Overview
The ultrasound needle guides market is highly fragmented, with numerous companies offering a variety of products across different regions and applications. This fragmentation is further driven by specialization, as many companies focus on niche areas like disposable or reusable guides, or guides designed for specific procedures. Key market players include Roper Technologies, Inc. (CIVCO Medical Solutions), Aspen Surgical Products, Inc., FUJIFILM Sonosite, Inc., Becton, Dickinson and Company (BD) and GE HealthCare, among others.
Ultrasound Needle Guides Market Leaders
-
Roper Technologies, Inc. (CIVCO Medical Solutions)
-
Aspen Surgical Products, Inc.
-
FUJIFILM Sonosite, Inc.
-
Becton, Dickinson and Company (BD)
-
GE HealthCare
- *Disclaimer: Major Players sorted in no particular order
Ultrasound Needle Guides Market News
- November 2024: DeepSight Technology, Inc. showcased its investigational NeedleVue LiteCart Ultrasound System at the Radiological Society of North America (RSNA) 2024. NeedleVue was designed to transform ultrasound-guided procedures by providing clear and reliable real-time visualization of needles, guidewires, and catheters, eliminating the need for radiation or complex calibration.
- September 2024: RIVANNA, a company specializing in innovative imaging-based medical solutions, acquired a cutting-edge ultrasound-guided needle insertion system patent. This newly patented technology (US Patent #11,432,801 B2) was designed to improve the accuracy and safety of needle-based medical procedures by enabling precise insertion into organs, tumors, fluid collections, and blood vessels for applications such as biopsy, ablation, injection, fluid aspiration, and catheter placement.
Ultrasound Needle Guides Industry Segmentation
Ultrasound needle guides are medical devices or accessories designed to work alongside ultrasound systems, ensuring precise and safe needle positioning during various medical procedures such as biopsy procedures and regional anesthesia, among others. The ultrasound needle guides market is segmented by product type, application, end-user and geography. By product type, the market is segmented into disposable needle guides and reusable needle guides. By application, the market is segmented into biopsy procedures, regional anesthesia, vascular access, fluid aspiration and drainage procedures, pain management and other interventional procedures. Other interventional procedures include tumor ablation, and musculoskeletal interventions, among others. By end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers and diagnostic imaging centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of USD value.
| By Product Type | Disposable Needle Guides | ||
| Reusable Needle Guides | |||
| By Application | Biopsy Procedures | ||
| Regional Anesthesia | |||
| Vascular Access | |||
| Fluid Aspiration and Drainage Procedures | |||
| Pain Management | |||
| Other Interventional Procedures | |||
| By End-User | Hospitals and Clinics | ||
| Ambulatory Surgical Centers | |||
| Diagnostic Imaging Centers | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Disposable Needle Guides |
| Reusable Needle Guides |
| Biopsy Procedures |
| Regional Anesthesia |
| Vascular Access |
| Fluid Aspiration and Drainage Procedures |
| Pain Management |
| Other Interventional Procedures |
| Hospitals and Clinics |
| Ambulatory Surgical Centers |
| Diagnostic Imaging Centers |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Ultrasound Needle Guides Market Research FAQs
How big is the Ultrasound Needle Guides Market?
The Ultrasound Needle Guides Market size is expected to reach USD 334.79 million in 2025 and grow at a CAGR of 5.09% to reach USD 450.98 million by 2030.
What is the current Ultrasound Needle Guides Market size?
In 2025, the Ultrasound Needle Guides Market size is expected to reach USD 334.79 million.
Who are the key players in Ultrasound Needle Guides Market?
Roper Technologies, Inc. (CIVCO Medical Solutions), Aspen Surgical Products, Inc., FUJIFILM Sonosite, Inc., Becton, Dickinson and Company (BD) and GE HealthCare are the major companies operating in the Ultrasound Needle Guides Market.
Which is the fastest growing region in Ultrasound Needle Guides Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Ultrasound Needle Guides Market?
In 2025, the North America accounts for the largest market share in Ultrasound Needle Guides Market.
What years does this Ultrasound Needle Guides Market cover, and what was the market size in 2024?
In 2024, the Ultrasound Needle Guides Market size was estimated at USD 317.75 million. The report covers the Ultrasound Needle Guides Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Ultrasound Needle Guides Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
